ABOUT CHIME BIOLOGICS
Chime Biologics, is a world-class experienced Contract Development and Manufacturing Organization (CDMO), providing customer-centric and cost-effective services for timely premier-quality biopharmaceutical development and manufacturing. We provide a comprehensive solution supporting our customers from analytical and process transfer to early-stage biopharmaceutical development through late-stage clinical and commercial drug substance and drug product manufacturing for Global Supply.
For more information on Chime Biologics, please visit www.chimebiologics.com.
CHIME BIOLOGICS CONTACTS
Business Contact
bd@chimebiologics.com
Location: China, Hubei, Wuhan
Employees: 201-500
Total raised: $190M
Founded date: 2013
Investors 1
| Date | Name | Website |
| - | Biomark Ca... | biomarkcap... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 27.03.2021 | Series A | $190M | - |
Mentions in press and media 11
| Date | Title | Description | Source |
| 07.03.2024 | Chime Biologics Achieves ISO 27001 Certification to Strength... | WUHAN, China, March 7, 2024 /PRNewswire/ -- Chime Biologics, a leading global CDMO that enables its ... | en.prnasia... |
| 26.10.2023 | Chime Biologics and Hope Medicine Enter Manufacturing Agreem... | Chime Biologics to support the late-stage clinical study and to provide global commercial manufactur... | en.prnasia... |
| 25.09.2023 | Chime Biologics Enters into a Strategic Cooperation Agreemen... | Chime Biologics has entered into a strategic collaboration with Kings Pharm for a biosimilar asset, ... | en.prnasia... |
| 22.09.2023 | Chime Biologics Announced Global Strategic Cooperation with ... | Chime Biologics and Panolos Bioscience have entered into a global strategic collaboration agreement ... | en.prnasia... |
| 30.06.2023 | Chime Biologics Announces Strategic Cooperation with Leads B... | Leads Biolabs and Chime Biologics initiate strategic cooperation to accelerate IND application and p... | en.prnasia... |
| 27.03.2021 | China’s Chime Biologics nets $190m funding led by VMS Group... | Premium Chime Biologics (Wuhan) Co., Ltd, contract development and manufacturing organisation, has c... | dealstreet... |
| 27.03.2021 | China’s Chime Biologics nets $190m funding led by VMS Group... | Chime Biologics (Wuhan) Co., Ltd, contract development and manufacturing organisation, has completed... | dealstreet... |
| 26.03.2021 | Chime Biologics Announced the Completion of $190 Million Ser... | March 26, 2021, Wuhan - Chime Biologics, a China-based, world-class CDMO company, announced today th... | biomarkcap... |
| 26.03.2021 | Chime Biologics Secures US$190M Series A+ Financing | Site-1 (Phase I plant in use) Chime Biologics, a Wuhan, China-based contract development and manufac... | finsmes.co... |
| 10.03.2020 | Chime Biologics Is Evolving into One of the Leading CDMOs in... | Wuhan, China, March 10, 2020 – Chime Biologics, a China-based, world-class Contract Development and ... | biomarkcap... |
Show more